記事
デジタルデータあり(Crossref)
すぐに読む
CiNii Research
Differential effect of canagliflozin, a sodium–glucose cotransporter 2 (SGLT2) inhibitor, on slow and fast skeletal muscles from nondiabetic mice
- 資料種別
- 記事
- 著者
- Hiroko Otsukaほか
- 出版者
- Portland Press Ltd.
- 出版年
- 2022-02-11
- 資料形態
- デジタル
- 掲載誌名
- Biochemical Journal 479 3
- 掲載ページ
- p.425-444
資料詳細
要約等:
- <jats:p>There has been a concern that sodium–glucose cotransporter 2 (SGLT2) inhibitors could reduce skeletal muscle mass and function. Here, we exami...
全国の図書館の所蔵
国立国会図書館以外の全国の図書館の所蔵状況を表示します。
所蔵のある図書館から取寄せることが可能かなど、資料の利用方法は、ご自身が利用されるお近くの図書館へご相談ください
書誌情報
この資料の詳細や典拠(同じ主題の資料を指すキーワード、著者名)等を確認できます。
デジタル
- 資料種別
- 記事
- 著者標目
- 出版年月日等
- 2022-02-11
- 出版年(W3CDTF)
- 2022-02-11
- タイトル(掲載誌)
- Biochemical Journal
- 巻号年月日等(掲載誌)
- 479 3
- 掲載巻
- 479
- 掲載号
- 3
- 掲載ページ
- 425-444
- 掲載年月日(W3CDTF)
- 2022-02-11
- ISSN(掲載誌)
- 02646021
- 出版事項(掲載誌)
- Portland Press Ltd.
- 対象利用者
- 一般
- DOI
- 10.1042/bcj20210700
- 作成日(W3CDTF)
- 2022-01-20
- 著作権情報
- https://creativecommons.org/licenses/by/4.0/
- 参照
- Elevated circulating level of β-aminoisobutyric acid (BAIBA) in heart failure patients with type 2 diabetes receiving sodium-glucose cotransporter 2 inhibitorsAssociation between SGLT2 Inhibitors and Cardiac Rehabilitation Outcomes in Patients with Cardiovascular Disease and Type 2 Diabetes Mellitus
- 参照
- Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASHDynamic Metabolome Analysis Reveals the Metabolic Fate of Medium-Chain Fatty Acids in AML12 CellsPrevalence and Determinant Factors of Sarcopenia in Patients With Type 2 DiabetesEmpagliflozin prevents from early cardiac injury post myocardial infarction in non-diabetic miceSodium–glucose cotransporter 2 inhibitor‐induced changes in body composition and simultaneous changes in metabolic profile: 52‐week prospective <scp>LIGHT</scp> (Luseogliflozin: the Components of Weight Loss in Japanese Patients with Type 2 Diabetes Mellitus) StudyTofogliflozin Improves Insulin Resistance in Skeletal Muscle and Accelerates Lipolysis in Adipose Tissue in Male MiceOrgan protection by SGLT2 inhibitors: role of metabolic energy and water conservationRegulation of Physiological and Metabolic Function of Muscle by Female Sex SteroidsInsulin Regulation of Proteostasis and Clinical ImplicationsIncreased grip strength with sodium–glucose cotransporter 2Muscle fiber type specificity in insulin signal transductionCombined effect of canagliflozin and exercise training on high-fat diet-fed miceEfficacy and safety of sodium‐glucose co‐transporter‐2 inhibitors in type 2 diabetes mellitus: systematic review and network meta‐analysisDapagliflozin attenuates steatosis in livers of high-fat diet-induced mice and oleic acid-treated L02 cells via regulating AMPK/mTOR pathwayEditorial: New Insights into Estrogen/Estrogen Receptor Effects in the Cardiac and Skeletal MuscleCanagliflozin, a sodium glucose cotransporter 2 inhibitor, attenuates obesity-induced inflammation in the nodose ganglion, hypothalamus, and skeletal muscle of miceHyperglycemia induces skeletal muscle atrophy via a WWP1/KLF15 axisWidely-targeted quantitative lipidomics method by supercritical fluid chromatography triple quadrupole mass spectrometryEffects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on MetforminType IIx myosin heavy chain transcripts are expressed in type IIb fibers of human skeletal muscleSlow-Twitch Fiber Proportion in Skeletal Muscle Correlates With Insulin ResponsivenessAge-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseasesHuman Muscle Fiber Type–Specific Insulin Signaling: Impact of Obesity and Type 2 DiabetesNon-alcoholic fatty liver disease in mice with hepatocyte-specific deletion of mitochondrial fission factorDapagliflozin Restores Impaired Autophagy and Suppresses Inflammation in High Glucose-Treated HK-2 CellsSarcopenia and Diabetes: Two Sides of the Same CoinInter-Laboratory Comparison of Metabolite Measurements for Metabolomics Data IntegrationControl of Ser2448 Phosphorylation in the Mammalian Target of Rapamycin by Insulin and Skeletal Muscle LoadCV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” HypothesisTSC2 Mediates Cellular Energy Response to Control Cell Growth and SurvivalLuseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot studyMuscle Fiber Type-Dependent Differences in the Regulation of Protein SynthesisDapagliflozin in Patients with Chronic Kidney DiseaseMetabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patientsAnalysis of the Effect of Canagliflozin on Renal Glucose Reabsorption and Progression of Hyperglycemia in Zucker Diabetic Fatty RatsFoxO3 Coordinately Activates Protein Degradation by the Autophagic/Lysosomal and Proteasomal Pathways in Atrophying Muscle CellsThe Relationship between Muscle Fiber Type-Specific PGC-1α Content and Mitochondrial Content Varies between Rodent Models and HumansInsulin and IGF-1 receptors regulate FoxO-mediated signaling in muscle proteostasisEmpagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesTOR Signaling in Growth and MetabolismA RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONAMP-activated Protein Kinase Suppresses Protein Synthesis in Rat Skeletal Muscle through Down-regulated Mammalian Target of Rapamycin (mTOR) SignalingSkeletal muscle inflammation and insulin resistance in obesityFoxO transcription factors: their roles in the maintenance of skeletal muscle homeostasisMitochondrial functional specialization in glycolytic and oxidative muscle fibers: tailoring the organelle for optimal functionSGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 InhibitorThe Na+/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP LevelsCardiovascular and Renal Outcomes with Empagliflozin in Heart FailureBrown Adipose Tissue Controls Skeletal Muscle Function via the Secretion of MyostatinDapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose productionMechanisms Modulating Skeletal Muscle PhenotypeDirect Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic PatientsMuscle type and fiber type specificity in muscle wastingDysregulation of the TSC-mTOR pathway in human diseaseA Novel Method to Measure Glucose Uptake and Myosin Heavy Chain Isoform Expression of Single Fibers From Rat Skeletal MuscleKetosis and diabetic ketoacidosis in response to SGLT2 inhibitors: Basic mechanisms and therapeutic perspectivesMuscle Fiber Composition and Capillary Density in Women and Men With NIDDMThe role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndromeIpragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight ReductionFiber Types in Mammalian Skeletal MusclesCanagliflozin and Renal Outcomes in Type 2 Diabetes and NephropathyDapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metforminFoxO3 Controls Autophagy in Skeletal Muscle In VivoNovel insights into the regulation of skeletal muscle protein synthesis as revealed by a new nonradioactive<i>in vivo</i>techniqueMechanisms for fiber-type specificity of skeletal muscle atrophyDapagliflozin in Patients with Heart Failure and Reduced Ejection FractionInsulin Activation of Rheb, a Mediator of mTOR/S6K/4E-BP Signaling, Is Inhibited by TSC1 and 2Wide target analysis of acylglycerols in miso (Japanese fermented soybean paste) by supercritical fluid chromatography coupled with triple quadrupole mass spectrometry and the analysis of the correlation between taste and both acylglycerols and free fatty acidsSkeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humansFoxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle AtrophyRecent advances in the regulation of the TOR pathway by insulin and nutrientsA direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cellsDapagliflozin Reduces Fat Mass without Affecting Muscle Mass in Type 2 Diabetes
- 連携機関・データベース
- 国立情報学研究所 : CiNii Research
- 提供元機関・データベース
- Crossref科学研究費助成事業データベース科学研究費助成事業データベース科学研究費助成事業データベース科学研究費助成事業データベース科学研究費助成事業データベース科学研究費助成事業データベース科学研究費助成事業データベースCrossrefCrossref